SMTL ID : 4c02.1

Crystal structure of human ACVR1 (ALK2) in complex with FKBP12.6 and dorsomorphin

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.17 Å

Oligo State

hetero-1-1-mer

Ligands

8 x FLC: CITRATE ANION(Non-covalent)

FLC.1: 5 residues within 4Å: Chain A: H.149, I.152, I.154, L.320, K.323 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:I.152 Water bridges: A:H.149, A:K.323, A:K.323, A:K.323 Salt bridges: A:H.149, A:K.323, A:K.323 FLC.2: 3 residues within 4Å: Chain A: F.155, G.156, Q.194 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:G.156, A:Q.194, A:Q.194 FLC.3: 7 residues within 4Å: Chain A: H.115, Y.116, H.117, E.118, K.176, K.177 Ligands: EDO.11 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:K.177 Hydrogen bonds: A:Y.116, A:H.117, A:E.118, A:K.177 Water bridges: A:M.119, A:K.177 Salt bridges: A:H.115, A:H.117, A:H.117, A:K.176, A:K.177 FLC.4: 12 residues within 4Å: Chain A: R.89, H.90, E.91, I.93, L.94, G.95, H.115, H.117, K.176, C.182 Ligands: EDO.11, EDO.14 9 PLIP interactions: 9 interactions with chain A Hydrogen bonds: A:H.90, A:G.95, A:H.115 Water bridges: A:H.115 Salt bridges: A:H.115, A:H.115, A:H.117, A:K.176, A:K.176 FLC.5: 7 residues within 4Å: Chain A: K.169, K.171, T.209, R.211, N.268, D.269, P.270 9 PLIP interactions: 9 interactions with chain A Hydrogen bonds: A:N.268, A:N.268, A:D.269 Water bridges: A:Y.123, A:Y.123 Salt bridges: A:K.169, A:K.171, A:K.171, A:R.211 FLC.6: 5 residues within 4Å: Chain A: T.318, L.320, R.321, K.324 Ligands: FLC.7 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:T.318 Water bridges: A:T.318 Salt bridges: A:R.321 FLC.7: 8 residues within 4Å: Chain A: A.148, H.151, I.152, K.231, T.318, A.319, L.320 Ligands: FLC.6 11 PLIP interactions: 11 interactions with chain A Hydrogen bonds: A:T.318, A:T.318, A:T.318, A:A.319, A:L.320 Water bridges: A:D.228, A:D.228, A:D.228, A:R.232 Salt bridges: A:K.231, A:K.231 FLC.18: 6 residues within 4Å: Chain A: M.101 Chain B: A.82, Y.83, G.84, A.85, T.86 4 PLIP interactions: 4 interactions with chain B Hydrogen bonds: B:A.85, B:T.86, B:T.86, B:T.86

1 x TAK: 6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine(Non-covalent)

TAK.8: 13 residues within 4Å: Chain A: V.45, V.53, A.64, K.66, L.94, T.114, H.115, Y.116, H.117, E.118, G.120, L.174, D.185 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:V.45, A:V.45, A:V.45, A:A.64, A:L.94, A:L.174 Hydrogen bonds: A:H.117 Water bridges: A:K.66

13 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.9: 5 residues within 4Å: Chain A: F.262, D.264, Q.284, R.285, N.287 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:N.287 Water bridges: A:F.262, A:N.287 EDO.10: 6 residues within 4Å: Chain A: C.226, D.228, S.229, R.232, P.313, S.314 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:D.228, A:S.314 EDO.11: 5 residues within 4Å: Chain A: E.91, K.176, N.178 Ligands: FLC.3, FLC.4 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:E.91, A:K.176 Water bridges: A:N.178 EDO.12: 2 residues within 4Å: Chain A: T.133, D.295 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:T.133 EDO.13: 4 residues within 4Å: Chain A: R.285, P.286, K.306, W.309 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:P.286 Water bridges: A:I.288 EDO.14: 6 residues within 4Å: Chain A: L.15, G.95, F.96, I.97, H.115 Ligands: FLC.4 2 PLIP interactions: 2 interactions with chain A Water bridges: A:F.96, A:F.96 EDO.15: 3 residues within 4Å: Chain A: R.33, R.37 Chain B: Q.54 4 PLIP interactions: 1 interactions with chain B, 3 interactions with chain A Hydrogen bonds: B:Q.54, A:R.33, A:R.37, A:R.37 EDO.16: 2 residues within 4Å: Chain A: L.42, E.43 No protein-ligand interaction detected (PLIP) EDO.17: 3 residues within 4Å: Chain A: N.62, Y.116, E.118 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:N.62 EDO.19: 4 residues within 4Å: Chain B: L.31, Q.32, N.33, P.93 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:N.33 Water bridges: B:Q.32 EDO.20: 4 residues within 4Å: Chain A: T.34, Q.38 Chain B: F.47, K.48 3 PLIP interactions: 2 interactions with chain B, 1 interactions with chain A Hydrogen bonds: B:K.48, A:Q.38 Water bridges: B:P.46 EDO.21: 6 residues within 4Å: Chain B: P.10, G.11, G.13, F.16, S.68, Q.71 5 PLIP interactions: 5 interactions with chain B Hydrogen bonds: B:G.11, B:G.11, B:G.13, B:S.68, B:S.68 EDO.22: 3 residues within 4Å: Chain B: I.51, G.52, E.61 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:E.61

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Williams, E. et al., Crystal Structure of Human Acvr1 (Alk2) in Complex with Fkbp12.6 And Dorsomorphin. Ph D Thesis

Release Date

2013-08-07

Peptides

ACTIVIN RECEPTOR TYPE-1: A
PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1B: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

ACTIVIN RECEPTOR TYPE-1

PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1B

Related Entries With Identical Sequence